Ospemifene: A Welcome Option for Treating Vaginal Atrophy

Andrew Kaunitz covers ospemifene, a new oral nonestrogenic therapy for vulvar and vaginal atrophy, and advises physicians on its benefits and risks.

Source: Medscape Pharmacists Podcast - March 20, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts